What are the latest developments in TAVI for aortic regurgitation?

Andreas Baumbach and Raj Makkar explore the latest developments in TAVI for aortic regurgitation. They review the emergence of dedicated transcatheter devices designed for patients with symptomatic aortic regurgitation who are at high surgical risk or unsuitable for surgery, and discuss the evidence supporting their use.

The conversation focuses on the ALIGN-AR study, examining its design, patient population, and key clinical outcomes, as well as the implications for daily practice. They also discuss current guideline recommendations and how transcatheter therapies may reshape the management of aortic regurgitation in the years ahead.

This interview was filmed at EuroPCR 2026: see more videos here.